Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Rujescu

Showing results (301-310 of 480) with videos related to

Pageof 48
Sort By:
Focus (American Psychiatric Publishing)|January 31, 2020
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching AntipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Biological Psychiatry|February 4, 2021
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode PsychosisThomas A Pollak, Angela Vincent, Conrad Iyegbe, et al.
Archives of General Psychiatry|October 6, 2010
Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controlsKristin K Nicodemus, Amanda J Law, Eugenia Radulescu, et al.
Schizophrenia Research|February 4, 2011
Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patientsThomas W Mühleisen, F Buket Basmanav, Andreas J Forstner, et al.
Frontiers in Public Health|September 15, 2016
Blood Levels of Monoamine Precursors and Smoking in Patients with SchizophreniaAshwin Jacob Mathai, Jyoti Kanwar, Olaoluwa Okusaga, et al.
Molecular Psychiatry|September 7, 2022
ABCB1 variants and sex affect serotonin transporter occupancy in the brainLeo R Silberbauer, Lucas Rischka, Chrysoula Vraka, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Intronic <i>FGF14</i> GAA repeat expansions are a common cause of downbeat nystagmus syndromes: frequency, phenotypic profile, and 4-aminopyridine treatment responseDavid Pellerin, Felix Heindl, Carlo Wilke, et al.
Molecular Medicine (Cambridge, Mass.)|June 7, 2012
Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophreniaAnne Kästner, Sabrina Grube, Ahmed El-Kordi, et al.
EMBO Molecular Medicine|March 21, 2014
Mild expression differences of MECP2 influencing aggressive social behaviorMartesa Tantra, Christian Hammer, Anne Kästner, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 21, 2016
Cognitive analysis of schizophrenia risk genes that function as epigenetic regulators of gene expressionLaura Whitton, Donna Cosgrove, Christopher Clarkson, et al.
Pageof 48

Showing results (301-310 of 480) with videos related to

Sort By:
Pageof 48
Focus (American Psychiatric Publishing)|January 31, 2020
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching AntipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Biological Psychiatry|February 4, 2021
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode PsychosisThomas A Pollak, Angela Vincent, Conrad Iyegbe, et al.
Archives of General Psychiatry|October 6, 2010
Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controlsKristin K Nicodemus, Amanda J Law, Eugenia Radulescu, et al.
Schizophrenia Research|February 4, 2011
Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patientsThomas W Mühleisen, F Buket Basmanav, Andreas J Forstner, et al.
Frontiers in Public Health|September 15, 2016
Blood Levels of Monoamine Precursors and Smoking in Patients with SchizophreniaAshwin Jacob Mathai, Jyoti Kanwar, Olaoluwa Okusaga, et al.
Molecular Psychiatry|September 7, 2022
ABCB1 variants and sex affect serotonin transporter occupancy in the brainLeo R Silberbauer, Lucas Rischka, Chrysoula Vraka, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Intronic <i>FGF14</i> GAA repeat expansions are a common cause of downbeat nystagmus syndromes: frequency, phenotypic profile, and 4-aminopyridine treatment responseDavid Pellerin, Felix Heindl, Carlo Wilke, et al.
Molecular Medicine (Cambridge, Mass.)|June 7, 2012
Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophreniaAnne Kästner, Sabrina Grube, Ahmed El-Kordi, et al.
EMBO Molecular Medicine|March 21, 2014
Mild expression differences of MECP2 influencing aggressive social behaviorMartesa Tantra, Christian Hammer, Anne Kästner, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 21, 2016
Cognitive analysis of schizophrenia risk genes that function as epigenetic regulators of gene expressionLaura Whitton, Donna Cosgrove, Christopher Clarkson, et al.
Pageof 48